

John Andrews, MD
Neurosurgery • Pediatric Neurosurgery


John Andrews, MD
Neurosurgery • Pediatric NeurosurgeryOn this page
About me
Dr. John P. Andrews is a neurosurgeon who cares for children with a broad range of neurological conditions, including tumors and vascular and functional disorders. He has a special focus on surgical treatments for epilepsy. His goal is to make the lives of children better.
In his research, Andrews focuses on finding genetic causes of seizures in children and discovering ways to change brain cell activity to stop seizures from occurring.
Andrews earned his medical degree from Yale University School of Medicine. He completed a residency in neurosurgery at UCSF, followed by a fellowship in pediatric neurosurgery at The Children's Hospital of Philadelphia.
In college, Andrews was an NCAA Division I varsity wrestler. His background in athletics taught him discipline, teamwork and the importance of preparing carefully for the moments that matter most. He prides himself on bringing that mindset to pediatric neurosurgery, striving to provide excellent care to improve the lives of children and help families feel supported and heard.
On social media, Andrews shares his candid views on medical education and neurosurgery training and advocates for science policy that will serve his patients.
Education & training
Residency
- Neurological Surgery, UCSF School of Medicine -GME
Internship
- Neurological Surgery, UCSF School of Medicine -GME
Degree
- MD, Yale University School of Medicine
My expertise
Specialties
- Neurosurgery
- Pediatric Neurosurgery
Locations
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
